Yearly Archives: 2019

How to Notify NIH about a Concern that Sexual Harassment is Affecting an NIH-Funded Activity at a Grantee Institution

Posted on by
Reply

As part of our continued efforts, we are pleased to announce a new webform that allows for anybody in the biomedical research community to share information related to a potential case of sexual harassment directly and, if desired, anonymously, to NIH. The establishment of this webform, in tandem with other actions, is taken as part of our continuing commitment to address the underlying culture that enables sexual harassment to take place. Continue reading →

Where to Post Informed Consent Forms for NIH-Funded Clinical Trials

Posted on by
Reply

The revised Common Rule requires that an IRB-approved version of an informed consent form be posted on a public federal website for all NIH-funded clinical trials. This must be done after enrollment ends and within 60 days of the last study visit. See Guide Notice NOT-OD-19-050. Continue reading →

Explore xTRACT Before Its Required Use in FY 2020

Posted on by
1

Beginning with RPPRs due on or after October 1, 2019 (FY 2020), recipients must use the xTRACT system to create the required training tables for submission with NIH and AHRQ T15, T32, T90/R90, and TL1 progress reports. While it is not mandatory to use xTRACT for new and renewal applications for the specified types of training grants, it may be required in future years. Continue reading →

Outcomes for NIH Loan Repayment Program Awardees: A Preliminary Look

Posted on by
Reply

Repaying educational debt is one thing, but what other benefits might these programs provide? To answer this question, my colleagues compared individuals that applied for and received an LRP with those who applied but did not receive an LRP award between fiscal years (FYs) 2003-2009. Their history of productivity was followed through FY 2017. More specifically, we assessed pulled information on grant submissions, awards, and publications in a sample that was equalized to control for baseline differences. Continue reading →

NIH Inclusion Data by Research and Disease Category Now Available

Posted on by
1

For over two decades, NIH has required researchers to include women, members of racial and ethnic minority groups, and children in their work absent an acceptable scientific or ethical rationale for their exclusion. Now, for the first time, selected inclusion data on sex/gender and race/ethnicity are publicly available disaggregated for various research, condition, and disease areas. Continue reading →

Sample Grant Applications, Summary Statements, and More

Posted on by
9

If you are new to writing grant applications, sometimes seeing how someone else has presented their idea can help as you are developing your own application. With the gracious permission of successful investigators, the National Institute of Allergy and Infectious Diseases (NIAID) makes available examples of funded R01, R03, R15, R21, SBIR/STTR, K, and F applications, summary statements, sharing plans, leadership plans, and more. Continue reading →

NIH Wants Your Input on Increasing Diversity Among Biomedical Research Faculty

Posted on by
25

Promoting scientific environments that can encourage and benefit from a full range of talent is necessary in biomedical research today. The NIH Common Fund is conducting strategic planning for a potential new program exploring ways to create a route of entry and advancement for talent from diverse backgrounds into independent academic faculty positions. NIH is seeking broad input on this approach from academic institutional leadership, biomedical faculty, and interested members of the public. Continue reading →

Redesigned eRA Website Provides New Resources

Posted on by
Reply

A newly revamped eRA website that serves as an informational gateway to applicants, grantees and reviewers was launched April 30. The site provides new and updated ‘how-to’ information on navigating eRA systems like eRA Commons, ASSIST, IAR, xTrain and xTRACT; intuitive navigation; and improved accessibility. Continue reading →

My resubmission of a competing renewal application (Type 2 A1) was not funded. May I submit a new renewal (Type 2 A0)?

Posted on by
1

No. Only a single resubmission of a competing new, revision, or renewal application (A0) will be accepted. After a resubmission of a competing renewal (Type 2) application that is not funded, a subsequent new renewal (Type 2 A0) application may not be submitted. The next application submitted on this topic should be submitted as a new application (Type 1 A0) on an appropriate due date for new applications (see NOT-OD-18-197 for exceptions). Continue reading →